1050 related articles for article (PubMed ID: 23882935)
1. [Evaluate the effectiveness of laser therapy in the treatment of diabetic maculopathy].
Mrugacz M; Krajewska M; Bryl A; Szuszkiewicz M
Pol Merkur Lekarski; 2013 Jun; 34(204):351-4. PubMed ID: 23882935
[TBL] [Abstract][Full Text] [Related]
2. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
[TBL] [Abstract][Full Text] [Related]
3. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME).
Akduman L; Olk RJ
Ophthalmic Surg Lasers; 1999; 30(9):706-14. PubMed ID: 10574491
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of diffuse diabetic macular edema by temporal grid pattern photocoagulation.
Shimura M; Yasuda K; Nakazawa T; Ota S; Tamai M
Ophthalmic Surg Lasers Imaging; 2004; 35(4):270-80. PubMed ID: 15305550
[TBL] [Abstract][Full Text] [Related]
6. Retinal architecture recovery after grid photocoagulation in diabetic macular edema observed in vivo by spectral domain optical coherence tomography.
Mylonas G; Bolz M; Kriechbaum K; Treu C; Deak G; Lammer J; Scholda C; Schmidt-Erfurth U
Retina; 2013 Apr; 33(4):717-25. PubMed ID: 23528703
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A
Retina; 2006; 26(9):999-1005. PubMed ID: 17151486
[TBL] [Abstract][Full Text] [Related]
8. [A grid pattern type of photocoagulation in treatment of diabetic maculopathy--personal experience].
Romaniuk W; Kozioł H; Markowska J; Fronczek M; Klimek J; Strojek K
Klin Oczna; 2000; 102(3):183-6. PubMed ID: 11126173
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of laser photocoagulation in clinically significant macular edema with focal versus diffuse parafoveal thickening on optical coherence tomography.
Barkmeier AJ; Nicholson BP; Akduman L
Ophthalmic Surg Lasers Imaging; 2009; 40(5):472-9. PubMed ID: 19772271
[TBL] [Abstract][Full Text] [Related]
10. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M
Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755
[TBL] [Abstract][Full Text] [Related]
11. Retina rejuvenation therapy for diabetic macular edema: a pilot study.
Pelosini L; Hamilton R; Mohamed M; Hamilton AM; Marshall J
Retina; 2013 Mar; 33(3):548-58. PubMed ID: 23023529
[TBL] [Abstract][Full Text] [Related]
12. Indocyanine Green Angiography-Guided Focal Laser Photocoagulation for Diabetic Macular Edema.
Ogura S; Yasukawa T; Kato A; Kuwayama S; Hamada S; Hirano Y; Uemura A; Yoshida M; Ogura Y
Ophthalmologica; 2015; 234(3):139-50. PubMed ID: 26393771
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.
Soliman W; Sander B; Soliman KA; Yehya S; Rahamn MS; Larsen M
Acta Ophthalmol; 2008 May; 86(3):284-91. PubMed ID: 18005220
[TBL] [Abstract][Full Text] [Related]
14. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.
Yanyali A; Nohutcu AF; Horozoglu F; Celik E
Am J Ophthalmol; 2005 May; 139(5):795-801. PubMed ID: 15860282
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.
; Fong DS; Strauber SF; Aiello LP; Beck RW; Callanan DG; Danis RP; Davis MD; Feman SS; Ferris F; Friedman SM; Garcia CA; Glassman AR; Han DP; Le D; Kollman C; Lauer AK; Recchia FM; Solomon SD
Arch Ophthalmol; 2007 Apr; 125(4):469-80. PubMed ID: 17420366
[TBL] [Abstract][Full Text] [Related]
16. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
Solaiman KA; Diab MM; Abo-Elenin M
Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
[TBL] [Abstract][Full Text] [Related]
18. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
Lee CM; Olk RJ; Akduman L
Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
Er H; Yilmaz H
Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
[TBL] [Abstract][Full Text] [Related]
20. The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.
Do DV; Schmidt-Erfurth U; Gonzalez VH; Gordon CM; Tolentino M; Berliner AJ; Vitti R; Rückert R; Sandbrink R; Stein D; Yang K; Beckmann K; Heier JS
Ophthalmology; 2011 Sep; 118(9):1819-26. PubMed ID: 21546089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
